Dupilumab treatment induces clinical remission in patients with uncontrolled, moderate-to-severe, type 2 inflammatory asthma

被引：0
|
作者：
Pavord, I. [1 ]
Pandit-Abid, N. [2 ]
Israel, E. [3 ,4 ]
Szefler, S. [5 ]
Brusselle, G. [6 ]
Rabe, K. [7 ,8 ]
Chen, Z. [9 ]
Altincatal, A. [10 ]
Amin, N. [9 ]
Khan, A. [11 ]
Lederer, D. H. [9 ]
Zhang, Y. [9 ]
Rowe, P. J. [2 ]
Deniz, Y. [9 ]
Amr, R. [9 ]
Jacob-Nara, J. A. [2 ]
Busse, W. W. [12 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Sanofi, Bridgewater, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Univ Colorado, Sch Med, Aurora, CO USA
[6] Ghent Univ Hosp, Ghent, Belgium
[7] LungenClin Grosshansdorf, Grosshansdorf, Germany
[8] Univ Kiel, Kiel, Germany
[9] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[10] Sanofi, Cambridge, MA USA
[11] Sanofi, Chilly Mazarin, France
[12] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000327
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [31] Effect of dupilumab on asthma control and asthma-related quality of life in patients with uncontrolled, moderate-to-severe type 2 asthma: TRAVERSE OLE study
    Busse, W.
    Pavord, I. D.
    Corren, J.
    Menzies-Gow, A.
    Heffler, E.
    Msihid, J.
    Siddiqui, S.
    Lederer, D. J.
    Hardin, M.
    Zhang, Y.
    Khan, A. H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [32] Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST
    Wenzel, S. E.
    Pavord, I.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Hamilton, J. D.
    Swanson, B. N.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] DUPILUMAB EFFICACY IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND SEROLOGIC EVIDENCE OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    Corren, J.
    Sher, L.
    Zhu, X.
    Rice, M.
    Deniz, Y.
    Rowe, P.
    Staudinger, H.
    Ruddy, M.
    Patel, N.
    Graham, N.
    Teper, A.
    Amin, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S15 - S15
  • [34] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma and Serologic Evidence of Allergic Bronchopulmonary Aspergillosis
    Corren, J.
    Sher, L.
    Zhu, X.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Staudinger, H. W.
    Ruddy, M.
    Patel, N.
    Graham, N. M. H.
    Teper, A.
    Amin, N.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [35] Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype
    Papadopoulos, Nikolaos
    Szefler, Stanley J.
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Domingo, Christian
    Daizadeh, Nadia
    Lederer, David J.
    Hardin, Megan
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Rowe, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [36] Dupilumab treatment induces rapid clinical improvement of itch in patients with moderate-to-severe atopic dermatitis
    Silverberg, Jonathan I.
    Eckert, Laurent
    Ardeleanu, Marius
    Chen, Zhen
    Akinlade, Bolanle
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozi, Gianluca
    Gadkari, Abhijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB113 - AB113
  • [37] Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma
    Papi, Alberto
    Corren, Jonathan
    Castro, Mario
    Domingo, Christian
    Rogers, Linda
    Chapman, Kenneth R.
    Jackson, Daniel J.
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    Ortiz, Benjamin
    ALLERGY, 2023, 78 (01) : 233 - 243
  • [38] Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma
    Pavord, Ian D.
    Rabe, Klaus F.
    Israel, Elliot
    Szefler, Stanley J.
    Brusselle, Guy
    Pandit-Abid, Nami
    Altincatal, Arman
    Chen, Zhen
    Amin, Nikhil
    Khan, Asif H.
    Lederer, David J.
    Zhang, Yi
    Rowe, Paul J.
    Deniz, Yamo
    Radwan, Amr
    Jacob-Nara, Juby A.
    Busse, William W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (01): : 132 - 142
  • [39] Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis
    Rhee, Chin Kook
    Park, Jung-Won
    Park, Heung-Woo
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (02) : 182 - 195
  • [40] Dupilumab for children with uncontrolled moderate or severe asthma
    Krandick, Guido
    MONATSSCHRIFT KINDERHEILKUNDE, 2022, 170 (03) : 196 - 197
12345